The contraceptive patch in relation to ischemic stroke and acute myocardial infarction

Pharmacotherapy

Volumn 27, Issue 2, 2007, Pages 218-220

  Jick, Susan S ^a   Jick, Hershel ^a  

^a BOSTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Contraceptive patch; Myocardial infarction; Oral contraceptive; Ortho EVRA; Stroke

Indexed keywords

ETHINYLESTRADIOL PLUS NORELGESTROMIN; ETHINYLESTRADIOL PLUS NORGESTIMATE;

ACUTE HEART INFARCTION; ADOLESCENT; ADULT; ARTICLE; CEREBROVASCULAR ACCIDENT; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HORMONAL CONTRACEPTION; HUMAN; INCIDENCE;

ADMINISTRATION, TOPICAL; ADOLESCENT; ADULT; BRAIN ISCHEMIA; CONTRACEPTIVE AGENTS; CONTRACEPTIVES, ORAL; FEMALE; HUMANS; INCIDENCE; MIDDLE AGED; MYOCARDIAL INFARCTION; NORGESTREL; RETROSPECTIVE STUDIES; STROKE;

EID: 33846837540     PISSN: 02770008     EISSN: None     Source Type: Journal    
DOI: 10.1592/phco.27.2.218     Document Type: Article

References (3)

1. Jick S, Kaye J, Russmann S, Jick H. Risk of non-fatal venous thromboembolism in women using a contraceptive transdermal patch and oral contraceptives containing norgestimate and 35 μg of ethinyl estradiol. Contraception 2006;73:223-8.
2. Jick S, Kaye J, Russmann S, Jick H. Risk of nonfatal venous thromboembolism with oral contraceptives containing norgestimate or desogestrel compared with oral contraceptives containing levonorgestrel. Contraception 2006;73:566-70.
3. Jick SS, Jick H. Cerebral venous sinus thrombosis in users of four hormonal contraceptives: levonorgestrel-containing oral contraceptives, norgestimate-containing oral contraceptives, desogestrel-containing oral contraceptives, and the contraceptive patch. Contraception 2006;74:290-2.